{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:30:40Z","timestamp":1697243440087},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s0014-2999(02)01488-7","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T03:23:56Z","timestamp":1027653836000},"page":"99-104","source":"Crossref","is-referenced-by-count":18,"title":["Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors"],"prefix":"10.1016","volume":"441","author":[{"given":"Teresa","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Manuela","family":"Morato","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Albino-Teixeira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0014-2999(02)01488-7_BIB1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-2999(90)90411-X","article-title":"Purine agonists prevent trophic changes caused by sympathetic denervation","volume":"179","author":"Albino-Teixeira","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB2","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1097\/00004872-199112006-00082","article-title":"Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat","volume":"9","author":"Albino-Teixeira","year":"1991","journal-title":"J. Hypertens., Suppl."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB3","first-page":"330","article-title":"Are fibroblasts adrenergically innervated cells?","volume":"18","author":"Azevedo","year":"1981","journal-title":"Blood Vessels"},{"key":"10.1016\/S0014-2999(02)01488-7_BIB4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/jm00382a018","article-title":"1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1 and A2-adenosine receptors","volume":"28","author":"Daly","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","article-title":"The physiological activity of adenine compounds with special reference to their action upon the mammalian heart","volume":"68","author":"Drury","year":"1929","journal-title":"J. Physiol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1748-1716.1958.tb01626.x","article-title":"Adaptive structural changes of the vascular walls in hypertension and their relation to the control of peripheral resistance","volume":"44","author":"Folkow","year":"1958","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0006-2952(80)90117-3","article-title":"Modulation of neurotransmission by purine nucleotides and nucleosides","volume":"29","author":"Fredholm","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1474-8673.1996.tb00055.x","article-title":"Hypertension due to chronic blockade of P1-purinoceptors","volume":"16","author":"Guimar\u00e3es","year":"1996","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/BF00169376","article-title":"Long-term administration of 1,3-dipropyl-8-sulfophenylxanthine (DPSPX) alters \u03b12-adrenoceptor-mediated effects at the pre- but not at the postjunctional level","volume":"350","author":"Guimar\u00e3es","year":"1994","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1476-5381.1995.tb14944.x","article-title":"Hypertension and enhanced \u03b2-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors","volume":"114","author":"Guimar\u00e3es","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-2999(89)90316-6","article-title":"Subsensitivity of presynaptic adenosine A1-receptors in caudal arteries of spontaneously hypertensive rats","volume":"174","author":"Illes","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pa.31.040191.000245","article-title":"Adenosine: a physiological brake on renin release","volume":"31","author":"Jackson","year":"1991","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0014-2999(80)90467-7","article-title":"Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats","volume":"66","author":"Kamikawa","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB14","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1476-5381.1995.tb16683.x","article-title":"Enhanced sympathetic neurotransmission in the tail artery of 1,3-dipropyl-8-sulfophenylxanthine (DPSPX)-treated rats","volume":"116","author":"Karoon","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB15","first-page":"112","article-title":"Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats","volume":"221","author":"Kawasaki","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.RES.66.3.637","article-title":"Endogenous adenosine restrains renin release in conscious rats","volume":"66","author":"Kuan","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(83)90352-7","article-title":"Effects of adenosine on [3H]norepinephrine release from perfused mesenteric arteries of SHR and renal hypertensive rats","volume":"87","author":"Kubo","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00004872-198610000-00001","article-title":"Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels?","volume":"4","author":"Lever","year":"1986","journal-title":"J. Hypertens."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(91)90206-6","article-title":"Long-term administration of 1,3-dipropyl-8-sulfophenylxanthine causes arterial hypertension","volume":"193","author":"Matias","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB20","first-page":"1","article-title":"Do resistance vessel abnormalities contribute to the elevated blood pressure of spontaneously-hypertensive rats? A review of some of the evidence","volume":"20","author":"Mulvany","year":"1983","journal-title":"Blood Vessels"},{"key":"10.1016\/S0014-2999(02)01488-7_BIB21","first-page":"224","article-title":"Is there a role for the vascular renin\u2013angiotensin system in the determination of vascular structure?","volume":"28","author":"Mulvany","year":"1991","journal-title":"Blood Vessels"},{"key":"10.1016\/S0014-2999(02)01488-7_BIB22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00496190","article-title":"Renal action of adenosine: effect on renin secretion in the rat","volume":"303","author":"Osswald","year":"1978","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.RES.56.4.525","article-title":"Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat","volume":"56","author":"Owens","year":"1985","journal-title":"Circ. Res."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB24","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1476-5381.1996.tb15591.x","article-title":"Augmented sensory-motor vasodilatation of the rat mesenteric arterial bed after chronic infusion of the P1-purinoceptor antagonist, DPSPX","volume":"118","author":"Ralevic","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB25","first-page":"422","article-title":"Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension","volume":"275","author":"Rubino","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB26","first-page":"F423","article-title":"A proposed role for adenosine in the regulation of renal hemodynamics and renin release","volume":"242","author":"Spielman","year":"1982","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0165-6147(90)90251-3","article-title":"Remodeling of the vascular tree in hypertension: drug effects","volume":"11","author":"Struyker Boudier","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB28","first-page":"351","article-title":"Purinergic inhibition of adrenergic transmission in rabbit blood vessels","volume":"204","author":"Su","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0014-2999(02)01488-7_BIB29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.pa.13.040173.001125","article-title":"The pharmacology of 6-hydroxydopamine","volume":"13","author":"Thoenen","year":"1973","journal-title":"Annu. Rev. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299902014887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299902014887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T14:52:19Z","timestamp":1555167139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299902014887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0014299902014887"],"URL":"https:\/\/doi.org\/10.1016\/s0014-2999(02)01488-7","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}